Royal Bafokeng Holdings, Zungu Pharmaceuticals, Temo Capital, and Global Capital Empowerment Fund’s acquisition of a 10.5% stake in Dis-Chem Pharmacies Limited in South Africa for ZAR 2.3 billion

Lead party: Royal Bafokeng Holdings (Pty) Ltd (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Dis-Chem Pharmacies Limited (public company) · Sector: Consumer Discretionary, Drug Retailers · Countries of operation: Namibia, South Africa, Botswana Transaction type: Merger/Acquisition(M&A) · Asset class: Private Equity · Instrument: Equity · Deal amount:…


Lead party: Royal Bafokeng Holdings (Pty) Ltd (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Dis-Chem Pharmacies Limited (public company) · Sector: Consumer Discretionary, Drug Retailers · Countries of operation: Namibia, South Africa, Botswana

Transaction type: Merger/Acquisition(M&A) · Asset class: Private Equity · Instrument: Equity · Deal amount: US$156.9m · Equity stake: 0.105% · Implied EV: US$1.49bn · Fund: GloCap Empowerment Fund 6

Lead investor/buyer: Royal Bafokeng Holdings (Pty) Ltd · Investors/buyers: Zungu Pharmaceuticals, Temo Capital , Zico, Glocap, Royal Bafokeng Holdings (Pty) Ltd

Legal advisers: not identified in the source record.

Source: announced 24 August 2021. Original announcement: bizcommunity.com.